As of Oct 18
| -0.095 / -0.19%|
The 10 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 70.50, with a high estimate of 79.00 and a low estimate of 59.00. The median estimate represents a +44.42% increase from the last price of 48.82.
The current consensus among 10 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.